Published in Lancet on July 29, 1989
Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China. Infect Immun (1992) 4.02
Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev (2000) 3.69
Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev (2010) 3.58
Global surveillance of communicable diseases. Emerg Infect Dis (1998) 2.50
Travel and the emergence of infectious diseases. Emerg Infect Dis (1996) 2.44
Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol (2004) 2.41
Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada. J Clin Microbiol (1991) 2.38
Molecular population genetic analysis of emerged bacterial pathogens: selected insights. Emerg Infect Dis (1996) 1.94
Characterization of Neisseria meningitidis isolated by ribosomal RNA gene restriction patterns and restriction endonuclease digestion of chromosomal DNA. Epidemiol Infect (1991) 1.89
Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes. J Clin Microbiol (2005) 1.82
Serogroup W-135 meningococcal disease during the Hajj, 2000. Emerg Infect Dis (2003) 1.81
Environmental and social influences on emerging infectious diseases: past, present and future. Philos Trans R Soc Lond B Biol Sci (2004) 1.57
Infectious diseases: an ecological perspective. BMJ (1996) 1.53
Clonal expansion of sequence type (ST-)5 and emergence of ST-7 in serogroup A meningococci, Africa. Emerg Infect Dis (2001) 1.50
Characterization of Neisseria meningitidis serogroup C by multilocus enzyme electrophoresis and ribosomal DNA restriction profiles (ribotyping). J Clin Microbiol (1992) 1.49
Characterization of epidemic and nonepidemic Neisseria meningitidis serogroup A strains from Sudan and Sweden. J Clin Microbiol (1990) 1.45
A predictable comeback: the second pandemic of infections caused by Neisseria meningitidis serogroup A subgroup III in Africa, 1995. Bull World Health Organ (1996) 1.35
Molecular epidemiology of serogroup a meningitis in Moscow, 1969 to 1997. Emerg Infect Dis (2001) 1.26
Epidemics of serogroup A Neisseria meningitidis of subgroup III in Africa, 1989-94. Epidemiol Infect (1996) 1.20
The 1998 Senegal epidemic of meningitis was due to the clonal expansion of A:4:P1.9, clone III-1, sequence type 5 Neisseria meningitidis strains. J Clin Microbiol (2000) 1.18
Pulsed-field gel electrophoresis analysis of clonal relationships among Neisseria meningitidis A strains from different outbreaks. Eur J Clin Microbiol Infect Dis (1997) 1.11
Epidemiological investigation of an outbreak of meningococcal meningitis in Makkah (Mecca), Saudi Arabia, 1992. Epidemiol Infect (1995) 1.11
Persistence of W135 Neisseria meningitidis carriage in returning Hajj pilgrims: risk for early and late transmission to household contacts. Emerg Infect Dis (2003) 1.06
Comparison of serogroup W-135 meningococci isolated in Sweden during a 23-year period and those associated with a recent hajj pilgrimage. J Clin Microbiol (2001) 1.00
Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in Brazil. J Infect (2010) 0.98
Emergence of a new clone of serogroup C Neisseria meningitidis in São Paulo, Brazil. J Clin Microbiol (1992) 0.96
Surveillance and control of meningococcal meningitis epidemics in refugee populations. Bull World Health Organ (1990) 0.95
Carriage of Neisseria species in communities with different rates of meningococcal disease. Can J Infect Dis (1992) 0.90
Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt. PLoS One (2013) 0.84
Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines. Arch Dis Child (2007) 0.84
The porA alleles are identical in subgroup III serogroup A Neisseria meningitidis strains isolated in China in the 1960s and 1980s. J Clin Microbiol (1996) 0.84
Absence of Neisseria meningitidis W-135 electrophoretic Type 37 during the Hajj, 2002. Emerg Infect Dis (2003) 0.80
Multilocus enzyme electrophoresis - Application to the study of meningococcal meningitis and listeriosis. Can J Infect Dis (1990) 0.75
Characterization of serogroup A Neisseria meningitidis from invasive meningococcal disease cases in Canada between 1979 and 2006: Epidemiological links to returning travellers. Can J Infect Dis Med Microbiol (2008) 0.75
Surveillance of Australian Hajj pilgrims for carriage of potentially pathogenic bacteria: Data from two pilot studies. World J Clin Cases (2017) 0.75
Preventative strategies on meningococcal disease. Arch Dis Child (1997) 0.75
Pasteurized milk as a vehicle of infection in an outbreak of listeriosis. N Engl J Med (1985) 11.94
Epidemic listeriosis--evidence for transmission by food. N Engl J Med (1983) 11.72
Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med (1996) 8.41
Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med (1980) 7.85
Listeriosis. JAMA (1989) 7.06
Prevention of Lyme disease after tick bites. A cost-effectiveness analysis. N Engl J Med (1992) 6.29
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15
The maintenance of key pecking by stimulus-contingent and response-independent food presentation. J Exp Anal Behav (1973) 6.12
Development of a chemically defined liquid medium for growth of Legionella pneumophila. J Clin Microbiol (1979) 6.10
Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J (1999) 5.88
Epidemiology of human listeriosis. Clin Microbiol Rev (1991) 5.21
Public health policy for preventing violence. Health Aff (Millwood) (1993) 5.17
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. Br J Cancer (2006) 4.93
Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA (1993) 4.63
Serogroup C meningococcal outbreaks in the United States. An emerging threat. JAMA (1995) 3.64
Two different kinds of key peck in the pigeon: some properties of responses maintained by negative and positive response-reinforcer contingencies. J Exp Anal Behav (1972) 3.57
The role of the response-reinforcer contingency in negative automaintenance. J Exp Anal Behav (1972) 3.52
Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA (1993) 3.31
High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci U S A (1999) 3.31
Resistant pneumococci: protecting patients through judicious use of antibiotics. Am Fam Physician (1997) 3.29
Epidemic of pediatric deaths from acute renal failure caused by diethylene glycol poisoning. Acute Renal Failure Investigation Team. JAMA (1998) 3.28
Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage (1996) 3.26
Evaluation of an algorithm for integrated management of childhood illness in an area of Kenya with high malaria transmission. Bull World Health Organ (1997) 3.20
emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis (1999) 3.12
Nonmenstrual toxic shock syndrome: a review of 130 cases. Ann Intern Med (1982) 3.12
Toxic-shock syndrome not associated with menstruation. A review of 54 cases. Lancet (1982) 3.10
Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA (1991) 3.09
Effects of reinforcement magnitude on pigeons' preference for different fixed-ratio schedules of reinforcement. J Exp Anal Behav (1969) 3.04
The carrier state: Neisseria meningitidis. J Antimicrob Chemother (1986) 3.00
Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol (2001) 2.92
Analysis of clinical and food-borne isolates of Listeria monocytogenes in the United States by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Appl Environ Microbiol (1990) 2.90
Amino acid requirements of Legionella pneumophila. J Clin Microbiol (1980) 2.88
Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study. JAMA (1985) 2.87
Development of complex, stereotyped behavior in pigeons. J Exp Anal Behav (1980) 2.85
Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med (1980) 2.85
Role of foods in sporadic listeriosis. I. Case-control study of dietary risk factors. The Listeria Study Group. JAMA (1992) 2.82
Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis (1990) 2.80
Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. JAMA (1990) 2.79
Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis (1999) 2.69
The social psychology of the gift. AJS (1967) 2.63
Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients. JAMA (1997) 2.62
Fungal infections: a growing threat. Public Health Rep (1996) 2.59
Validation of Legionella pneumophila indirect immunofluorescence assay with epidemic sera. J Clin Microbiol (1981) 2.56
Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995. J Clin Microbiol (1997) 2.55
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours. Br J Cancer (2005) 2.49
Discriminative stimulus location as a determinant of positive and negative behavioral contrast in the pigeon. J Exp Anal Behav (1975) 2.47
Investigation of an outbreak of listeriosis: new hypotheses for the etiology of epidemic Listeria monocytogenes infections. J Infect Dis (1989) 2.42
Association of sporadic listeriosis with consumption of uncooked hot dogs and undercooked chicken. Lancet (1988) 2.42
Maintenance of key pecking by response-independent food presentation: the role of the modality of the signal for food. J Exp Anal Behav (1973) 2.42
Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet (1985) 2.39
Antimicrobial use for pediatric upper respiratory infections: reported practice, actual practice, and parent beliefs. Pediatrics (1999) 2.34
Photogrammetric measurement of nerve fiber layer thickness. Ophthalmology (1989) 2.34
Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun (1993) 2.32
Discrete-trials spaced responding in the pigeon: the dependence of efficient performance on the availability of a stimulus for collateral pecking. J Exp Anal Behav (1971) 2.31
Analysis of Listeria monocytogenes by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Int J Food Microbiol (1989) 2.29
Reactivity of serum from patients with suspected legionellosis against 29 antigens of legionellaceae and Legionella-like organisms by indirect immunofluorescence assay. J Infect Dis (1983) 2.28
Pneumococcal vaccine efficacy in selected populations in the United States. Ann Intern Med (1986) 2.26
Behavioral contrast in the pigeon: a study of the duration of key pecking maintained on multiple schedules of reinforcement. J Exp Anal Behav (1975) 2.19
Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr (1996) 2.17
Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins. JAMA (1985) 2.16
Role of foods in sporadic listeriosis. II. Microbiologic and epidemiologic investigation. The Listeria Study Group. JAMA (1992) 2.15
Toxic shock syndrome surveillance in the United States, 1980 to 1981. Ann Intern Med (1982) 2.14
Metal requirements of Legionella pneumophila. J Clin Microbiol (1981) 2.12
Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C. J Clin Microbiol (2001) 2.12
Molecular epidemiology of diphtheria in Russia, 1985-1994. J Infect Dis (1996) 2.12
Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland. J Infect Dis (1998) 2.11
Global epidemiology of meningococcal disease. Clin Microbiol Rev (1989) 2.11
Failure to produce response variability with reinforcement. J Exp Anal Behav (1982) 2.07
Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis. Lancet (1988) 2.06
Group A meningococcal carriage in travelers returning from Saudi Arabia. JAMA (1988) 2.06
Epidemiologic aspects of legionellosis. Epidemiol Rev (1979) 2.03
Identifying sick children requiring referral to hospital in Bangladesh. Bull World Health Organ (1997) 2.00
Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies. Pediatr Infect Dis J (1995) 2.00
Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex. Emerg Infect Dis (2000) 1.97
Comparison of ribotyping and multilocus enzyme electrophoresis for subtyping of Listeria monocytogenes isolates. J Clin Microbiol (1994) 1.96
Use of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in Pakistan for surveillance for antimicrobial resistance. Pediatr Infect Dis J (1993) 1.95
Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study. Br J Psychiatry (1997) 1.93
Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves. Nat Med (1999) 1.92
Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment. JAMA (1985) 1.91
Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics (2000) 1.91
Meningococcal disease in Los Angeles County, California, and among men in the county jails. N Engl J Med (1996) 1.89
Infection caused by Francisella philomiragia (formerly Yersinia philomiragia). A newly recognized human pathogen. Ann Intern Med (1989) 1.89
Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis (2000) 1.89
Why do physicians prescribe antibiotics for children with upper respiratory tract infections? JAMA (1998) 1.89
Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project. J Infect Dis (1995) 1.88
Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J Infect Dis (1997) 1.86
Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America. Pediatrics (1999) 1.85
The epidemiology of listeriosis in the United States--1986. Listeriosis Study Group. Am J Epidemiol (1991) 1.84
Absence of siderophore activity in Legionella species grown in iron-deficient media. J Bacteriol (1983) 1.77
Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis (1990) 1.77